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ABSTRACT  
Objective: Thermo-modulated in-situ hydrogel (TSHG) are formulated routinely utilizing poloxamer for extended drug release. However 
physical properties of such formulations may have some flaws, which can be rectified using a combination of polymers with bet ter physical 
properties such as chitosan. The purpose of the present study was to fabricate biodegradable chitosan-poloxamer-based in-situ drug delivery 
systems and assessment of their physical properties.  
Methods: The present chitosan-poloxamer gel base was formulated using a two-stage method. Initially, chitosan gel was prepared by dissolving 
1% w/w chitosan in glacial acetic acid. The poloxamer gel was prepared using “cold method”. The final chitosan-poloxamer gel base was 
prepared by mixing equal amounts of both solutions and evaluated for physical and mechanical properties.  
Result and Discussion: The DSC thermogram demonstrated no obvious interactions among ingredients or micellization temperature. The 
gelation temperature of the gel was between 27 and 330C. The pH was 7 with slight clarity. The viscosity of the gel ranged from 15.14 to 41.19 
pa.s. The gel was syringable between 4-300C and biodegradable under physiological conditions. The mean particle size of the gel under SEM 
was found in the range of 300-554 nm.  
Conclusion: After the evaluation of the formulation, it can be concluded that all the ingredients in the gel showed good compatibility wi th each 
other, which could form a stable and homogeneous gel with favorable mechanical and physical properties.  
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INTRODUCTION 
Inventions, besides technological advancements in biogenic 
natural or synthetic polymers, have shown few promising 
results using targeted drug delivery systems. Among the 
recently proposed materials, linear aliphatic polyesters, 
polyanhydrides, poly (orthoesters), proteins1, polylactic acid, 
polyglycolic acid, and copolymers have extensive 
applications in local drug-delivery systems.2 The 
embodiment of microparticulate drug molecules in 
biodegradable polymers is a suitable alternative to some 
complex medical and dental procedures. Numerous synthetic 
microspheres are biocompatible, degradable, and easily 
convertible to three-dimensional matrixes of variable 
structures.2 The polysaccharides recommended for such 
purposes include chitin, chitosan, poloxamer, carboxymethyl 
cellulose, agar, and alginate which are naturally occurring 
cationic biopolymer.  
Apart from its derivation from crustaceans’ shells, and the 
result of the diacylation of chitin3,4; chitosan exhibits several 
physicochemical properties like blending5, Schiff base 
formation6, compatibility with other bioactive agents7, 
superior biocompatibility, nontoxicity, hemostatic and 
antimicrobial properties as well. Chitosan is utilized in a 
wide variety of medical applications such as in situ gels for 
Dahake et al                                                                                                                         Journal of Drug Delivery & Therapeutics. 2020; 10(4):59-66 
ISSN: 2250-1177                                                                                        [60]                                                                                    CODEN (USA): JDDTAO 
topical application, wound dressing, tissue engineering, and 
health-care food. It can enhance fibroblast growth, 
macrophage activation, and hemostasis secondary to wound 
sealing properties.7 Poloxamer 407 (P407), also termed as 
Pluronic F127, is a routinely utilized polymer to formulate 
thermo-modulated in-situ hydrogel (TSHG) for extended 
drug release.8 It can harbor both hydrophilic and 
hydrophobic drug molecules.9 Hence, such a polymer can be 
effectively utilized for stabilizing single-dose 
macromolecular formulations. P407 is a commercially 
available member of the poly(ethylene oxide-b-propylene 
oxide-b-ethylene oxide) triblock copolymer family.10 It has 
been utilized as a controlled release vehicle for many 
macromolecular drugs with variable molecular weights. The 
methods to prepare drug-loaded TSHGs relatively is modest, 
utilizing the mixing of ingredients only and sidestepping 
farthest settings such as heating, the addition of organic 
solvents, or chemical crosslinking agents. There are 
experimental studies that have evaluated the effect of 
individual polymers as drug delivery systems.11 Very few 
experimental studies have attempted to evaluate poloxamer-
modified chitosan gels as biologically acceptable bases to 
improve retention and harmonize their controlled release 
domain via in-situ ionotropic gelation.  
Consequently, the present study was purposed to formulate 
a biodegradable chitosan-poloxamer in-situ gel base system 
for local drug delivery. 
MATERIALS AND METHODS 
The present in vitro study was conducted at the Department 
of Pediatric and Preventive Dentistry in association with the 
Department of Pharmaceutics after gaining clearance from 
the Institutional Ethical Committee, letter no. 
DMIMS(DU)/IEC/2015-16/1744, Dated: 31/12/2015.   
Materials used for the formulation of the gel base: All 
materials and chemicals were used in the present 
experiment were of analytical grade. The quantity and names 
of various suppliers are mentioned in Table 1. 
  
Table 1: Ingredients used in the gel formulation 
Ingredients Quantity Supplier  
Chitosan  1% w/w HiMedia Laboratories, Mumbai, India.  
Poloxamer 407 15% w/w Sigma-Aldrich Mumbai.  
Carbopol 940 0.5 % w/w Akhil Healthcare Private Limited, Gujarat, India. 
Triethanolamine 2 drops v/v Merck Specialities Pvt. Ltd, Mumbai. 
Methyl paraben 0.15% w/w Sigma Aldrich, Mumbai. 
Hydrochloric acid 0.1% w/w Merck Specialities Pvt. Ltd, Mumbai. 
Propylene glycol 10% w/w Merck Specialities Pvt. Ltd, Mumbai. 
Polyethylene glycol-200 10% w/w Merck Specialities Pvt. Ltd, Mumbai. 
Isopropyl alcohol 10% w/w Sigma-Aldrich, Mumbai. 
Glacial acetic acid 2% w/w Fisher Scientific India, Pvt. Ltd, Mumbai. 
 
 
Preparation of chitosan-poloxamer-based gels:  
A two-stage formulation was utilized to prepare the 
chitosan- poloxamer gel base. Initially, chitosan gel was 
prepared by following the method mentioned in a previously 
sited literature report.12 Chitosan (1% w/w) was dissolved 
gradually in aqueous glacial acetic acid (2% w/v) 
continuously with slow stirring until complete dissolution. 
Carbopol 940 (0.5% w/w) was precisely measured and 
thawed slowly in double de-ionized distilled water through 
continuous magnetic stirrer mixing at 200 rpm. Both 
solutions were further blended with continuous stirring. 
Once the carbopol chitosan solution was prepared, PEG 200 
(10% w/v), propylene glycol (10% w/v), isopropyl alcohol 
(10% w/v), and 2 drops of triethanolamine were added 
gradually12 to achieve a clear solution. To prepare the 
poloxamer gel, the “cold method” was used as stated by 
Matthew et al. For this purpose, the precisely measured 
amount of polymer was poured into a flat bottom flask 
followed by the addition of distilled water and 0.9% NaCl to 
wet it completely with nonstop magnetic stirrer agitation at 
100 rpm for 1 h at room temperature to give partially 
dissolved solutions. PEG (10%) was added to this solution 
with constant magnetic agitation at 100 rpm. This solution 
was further stored at 4ºC for 24 h until the entire polymer 
was completely dissolved to obtain a clear solution.13 The 
refrigerated chitosan gel was utilized as a solvent for 
poloxamer dispersion. The final solution of chitosan-
poloxamer was prepared by adding an equal amount of both 
solutions with a continuous stirring mode of 200 rpm for 1 h. 
At last, methylparaben was incorporated as a preservative. 
The gel pH was adjusted by adding 0.1% HCl (w/v) to 7.0. 
The solution thus derived was partially dissolved hence 
refrigerated again at 40C for 24 h until a clear solution was 
achieved. This procedure gave a clear tacky solution at the 
end of 40C.  
Study of physical interaction between ingredients by 
differential scanning calorimetry (DSC) study: 3-5 mg of 
the gel formulation was loaded in an aluminum pan carefully 
for calorimetric analysis. The pan was carefully sealed by 
crimping the lid. An empty crimped aluminum pan was used 
for standard reference. DSC analysis of the gel was 
performed on a DSC-25 Mettler Toldo system equipped with 
a refrigerated cooling system and Stare software apparatus 
(Mettler Toledo, DSC 823e, Greifensee, Switzerland). The 
experimental and reference pans were heated at 
predetermined temperature modules in a nitrogen 
atmosphere at 10ºC/min, between 20 and 4000C. Nitrogen 
was released at 20 ml/min flow rate at 2 bars. The scans 
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were documented, and heat flow-temperature plots were 
obtained.14 The recorded thermogram was verified with 
individual excipient thermograms to analyze the 
compatibility and interaction of the excipients with each 
other.15  
Physical appearance and pH: The formulations were 
assessed through visual examination for clarity in front of 
black and white backgrounds to categorize them as: very 
clear [+++], clear [++], and turbid [+].16,17 Before estimating 
the pH of the gel formulation, the equipment was 
standardized in the range of 4-9 using standard buffer 
solutions. Later pH of the gel was estimated by plunging the 
glass electrode entirely into the gel.16   
Measurement of gelation temperature and time: The 
gelation temperature of the gel was measured utilizing the 
process designated by Garala et al.18 A volume of 3-4 mL gel 
was transported in a test tube and sealed with paraffin wax. 
The assembly was dipped in a water bath maintained at 4 °C. 
The bath temperature was increased incrementally by 2°C 
per minute for 25 mins (range 40C-540C). The gelation 
temperature of the formulation was noted at the point where 
the meniscus no longer moved by tilting the test tube by 
more than 900 angles.8,19 To calculate the gelling time, 5ml 
sol maintained at 40C was added to a transparent vial with a 
magnetic stirrer and placed immediately in a water bath 
(370C). The stirring rate of the bar was set at 50 rpm. The 
time when the sol was converted into the gel and the 
magnetic bar lost movements due to loss of fluidity was 
considered as the gelation time.8   
Measurement of viscosity: To determine the viscosity of 
the gel, 1ml of the sample was added to a coaxial cylinder 
viscometer (RST-CC Rheometer, Brookfield Engineering 
Labs, Inc. Middleboro, USA) that contained a cone with an 
angle of 10, inverted on a stainless-steel cylinder. The 
viscosity of the gel was estimated at room temperature 
(range 25-270C) with a constant shear rate of 6.5/s at a time 
interval of 4 s (range 4–40 s), in ascending and descending 
manner.8   
Texture profile analysis (TPA): Texture profile analysis 
(TPA) was assessed in vitro utilizing a CT3 Texture 
Analyzer (with Texture-Pro CT Software, Brookfield 
Engineering Labs, Inc. Middleboro, USA) in TPA mode, as 
recently portrayed.11,20 Sample (35 g) was added to 50-
ml bottles, dodging air incorporation into the sample. 
The analytical probe (10 mm diameter) was twofold 
trampled into the formulation at a predetermined rate of 
0.5 mm/s to a specified depth of 4 mm. A delay period of 15 
s was permitted amid two compressions at room 
temperature (range 25-27 0C). From the subsequent 
force-time plots, the hardness, compressibility, 
adhesiveness, cohesiveness, stringiness, fracturability, and 
springiness were estimated.20  
Measurement of Spreadability: The spreadability of the gel 
was estimated with a CT3 Texture Analyzer (with Texture-
Pro CT Software, Brookfield Engineering Labs, Inc. 
Middleboro, USA) in TPA mode. For that, a set of matched 
male and female Perspex cones was utilized. All the 
procedures were followed as explained in the company 
manual to set up machine assembly precisely, before testing. 
A conical analytical probe sample holder (30 mm diameter, 
600) was filled with the gel using a spatula, and its surface 
was leveled with a flat knife. The conical probe was enforced 
into the sample holder at a pretest speed of 1 mm/s. At a 
trigger force of 10 g, the probe pierced the gel at 2 mm/s test 
speed for 25 mm depth. After penetration at a specified 
depth, the probe was retracted from the sample at 2 mm/s 
posttest speed. The subsequent force-time plot thus derived, 
was the spreadability of the gel.17  
In vitro mucoadhesive strength: The mucoadhesive quality 
of the gel formulation was assessed in vitro through the force 
essential to detach it from goat cheek mucosa11, utilizing a 
CT3 Texture Analyzer (with Texture-Pro CT Software, 
Brookfield Engineering Labs, Inc. Middleboro, USA).20 The 
gel was packed into a 30 mm diameter tube and centrifuged 
to remove the entrapped air from it, creating a smooth 
surface. A fresh piece of goat cheek mucosa was obtained and 
trimmed to dimensions of (20 × 20 mm). It was cleaned with 
a phosphate buffer solution (pH 6.8). The mucosa sheet was 
secured onto the tissue holder, with the orifice of the lid 
open to expose a small section of the mucosa in a 500 mL 
beaker with simulated saliva at 37 ± 0.50C through a 
thermostat. The tissue holder was kept in a beaker with 
stirring to equilibrate at this temperature for 15 mins. The 
gel was positioned on the mucosal surface through the 
holder orifice, followed by lowering of the probe assembly on 
the gel surface at 0.1 mm/s continuous speed and, of 7 g 
contact force. After 120 s of contact, the probe was uplifted 
with 1.0 mm/s speed. The area under the curve (AUC) was 
considered from the force-distance plot as a function of 
mucoadhesion.21   
Measurement of Tensile strength: The mechanical 
properties of the gel formulation were estimated with a CT3 
Texture Analyzer (with Texture-Pro CT Software, 
Brookfield Engineering Labs, Inc. Middleboro, USA), 
armed with 7 g of a load cell. The gel was positioned in a 30 
mm tube after freeing from air bubbles and inadequacies, 
and a 10 mm analytical probe was twofold trampled into 
the gel at a predetermined rate of 0.5 mm/s to 4 mm depth 
at room temperature. A delay period of 15 s was allotted for 
two cycles. The subsequent force-time plots for tensile 
strength for percentage elongation were measured when the 
gel broke.22  
Syringability study: The flowability of the gel was analyzed 
through their syringeability and injectability by utilizing 
needles like clinical situations or small lab animals like rats 
or mice.23 Through the procedure of withdrawing 1ml of the 
refrigerated gel employing 25G (0.5mm×19mm) and 22G 
(0.65mm×25mm) needles, was utilized to evaluate the 
syringeability of the chitosan-poloxamer gel. Similarly, the 
gel injectability was estimated by regulating it through the 
same gauge needles affixed to a standard 1ml syringe with a 
Luer-Lok system (DISPOVAN, Faridabad, U.P., India).24 The 
criteria followed were classified as (i) injectable suspension 
(a free-flowing suspension of fine suspended particles that 
passes easily through a 25G needle without noticeable 
resistance); (ii) injectable gel (a solution that passes through 
a 25G needle with some resistance and emerges as a stream 
of coagulated gel); (iii) administrable gels (a solution that is 
difficult to push through a 25G needle and emerges in the 
form of gel droplets rather than a stream); or (iv) semisolid 
gel (a gel solution that cannot be injected through a 25G 
needle but passes easily through a 22G needle, emerging as a 
thick gel).24 The gel was stored at 4-80C before 
syringeability/injectability testing.  
Biodegradability test: The biodegradability of the gel 
formulation was reviewed as per previously published 
literature.25,26 Momentarily, 100 mg sample was transported 
and incubated into a glass tube comprising 10 mL of 
phosphate buffer solution (pH 7.0) followed by 
supplementation with 13 mg/L lysozyme solutions (like in 
human serum). The blends were kept at 370C with 
continuous agitation at 60 rpm for various time intervals (1, 
2, 4, 6, 8, and 10 days). The lysozyme solution was 
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replenished every day. Toward the finish point of every 
degradation period, the sample was gathered from the 
medium, washed with deionized distilled water, and dried at 
500C in a heated vacuum chamber until consistent weight. 
The test was repeated in triplicate, and the weight loss (%) 
was determined by the accompanying equation.  
Weight loss % = 
     
  
     
Wi is the initial weight of the sample and Wf is the final 
weight of the sample after degradation.  
SEM Analysis of the gel: The gel formulation sample was 
kept at room temperature for 48 h in a vacuum desiccator to 
expel any leftover solvent. After mounting the gel sample 
formulation on the holding device and Au-Pd sputtering, its 
morphology was imaged at 15 keV under a scanning electron 
microscope Zeiss EVO-50XVP, (Carl Zeiss SMT, Inc., Peabody, 
MA, USA). The structural arrangements of the polymeric 
contents, their orientation, and average particle diameter 
were determined based on two distinctive SEM micrographs 
and in all 3 estimations utilizing an image analysis 
program.24,25  
RESULTS AND DISCUSSION  
Preparation of chitosan-poloxamer-based gels: This 
study aimed to develop a biodegradable chitosan-poloxamer 
gel base for sustained release using chitosan, carbopol as the 
primary ingredients. Whereas, P407 as a polymer additive to 
achieve high performance in situ thermo-reversible matrix 
gel. Previous reports have elaborated on the poloxamer gel’s 
restricted ability to dissolve quickly in biological and 
functional environments.27 Chitosan harbors very good 
mucoadhesive properties and augments the gel strength 
when added at a proper ratio. In the existing study, polymers 
were added as a second system based on the investigations 
and reports from previous literature.28  
Study of physical interaction between ingredients DSC: 
DSC (Differential Scanning Calorimetry) was utilized in the 
pharmaceutical field to establish the identity and purity of 
solid-state systems. It is also used to detect the interaction of 
the ingredients used in a formulation, and hence, can be 
utilized for the selection of suitable and chemically 
compatible ingredients. The thermogram of the gel with all 
polymers and other ingredients is presented in Figure 1. 
Chitosan demonstrated a single, defined endothermic peak 
onset at 124.54°C, and the peak was obtained at 157.210c. 
While poloxamer demonstrated an endothermic peak at 53 
°C, however, characteristic peaks of other excipients were 
unobserved in this figure. Secondly, there was no evidence of 
any new peak with any of the individual content, suggesting 
no evidence of excipients and polymer interactions. In this 
study, DSC was used to study the effects of chitosan and 
carbopol on the micellization of poloxamer through the 
critical micellization temperature of the gel. Both the major 
ingredients, chitosan, and poloxamer, showed typical and 
clear endothermic peaks, indicative of micellization. This 
peak is the result of P407 hydrophobic polypropylene oxide 
(PPO) block dehydration, through the passage of their 
micellization, as mentioned in previous reports.29,30 The 
thermogram obtained from poloxamer shows lower values of 
Tonset, Tpeak, and Tendset compared to chitosan. Carbopol and 
other additives did not disclose significant peaks or changes 
in the present thermogram. Similarly, the effects of chitosan 
and carbopol addition on the micellization of P407 were 
relatively tangible and did not cause any visible alteration in 
the critical micellization temperature of any ingredient. 
   
 
Figure 1: DSC thermogram of the gel formulation 
 
Physical appearance and pH: The physical appearance of 
the gel was graded clear with a mean value of ++. The clarity 
of the gel formulation can be attributed to the non-presence 
of drug molecules at this phase of a formulation. Likewise, it 
was not very clear and transparent due to few excipients 
having different refractive indices, altering the gel clarity 
slightly. The mean pH of the present gel was found 7 (with a 
range of 6.9–7.1) [Table 2].   
 
Table 2: Gelation temperature, time pH, and physical 
appearance of the gel 
Sr. No. Parameter  Readings 
1.  Gelation temperature  330C 
2.  Gelation time at 370C 25 secs 
3.  pH  7 
4.  Physical appearance  ++  
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Measurement of gelation temperature and time: The 
gelation temperature of the gel was between 27 and 330C. 
The gelation time of the present formulation at 370C was 
found to be 25 s (Table 2). Certain external triggers alter the 
gelation temperature and time of such preparations, like a 
solvent exchange, ionic cross-linkage, pH change, or UV 
radiation. The internal triggers that alter gel behavior are 
the concentration of the ingredients, as mentioned in 
previous literature.12     
Measurement of viscosity: In general, an essential factor 
for an in-situ gel is the gelation temperatures and viscosity 
whenever applied at the target site for a prolonged stay. 
Gelation temperature in the range of 25–37 °C is appropriate 
as the internal temperature ranges between 36-380C. Hence, 
the study was aimed to prepare an injectable/insertable 
thermo-reversible in-situ gel system with a gel-sol transition 
temperature range of 27-330C. As presented in Table 3 and 
Graph 1, the viscosity of the formulation decreased with an 
increase in shear stress and shear rate. The viscosity of the 
gel ranged from 15.14 to 41.19 pa.s. 
  
Table 3: Viscosity analysis of the gel formulation at room temperature 
Sr. No.  Time (s) Shear stress (Pa) Shear rate (1/s) Viscosity (Pa.s) 
1 4 00.00 0.00 0.00 
2 8 264.29 6.47 40.82 
3 12 324.61 12.97 25.03 
4 16 363.63 19.46 18.69 
5 20 395.01 25.94 15.23 
1 24 392.68 25.94 15.14 
2 28 357.71 19.45 18.39 
3 32 319.24 12.97 24.62 
4 36 267.07 06.49 41.19 
5 40 42.98 0.000 00.00 
 
 
Graph 1: Viscosity analysis of the gel formulation. 
 
Texture profile analysis: Texture profile analysis of the 
present in-situ gel formulation at a peak load of 32 g showed 
hardness up to 3.97 mm, adhesiveness of 0.4mJ, stringiness 
of 1.97 mm, fracture deformation at 0.03 mm (7 g load), the 
cohesiveness of 0.98, and springiness of 3.08 mm (Table 4). 
These outcomes demonstrated the relevance of gels to target 
sites or adhesion capacity revealing the retainability of the 
gel there. Hardness values affirmed the immovability of the 
gel, while cohesiveness demonstrated better consistency. 
This will be helpful in cohesion resistance of the formulation 
in function. 
  
 
  
Dahake et al                                                                                                                         Journal of Drug Delivery & Therapeutics. 2020; 10(4):59-66 
ISSN: 2250-1177                                                                                        [64]                                                                                    CODEN (USA): JDDTAO 
Table 4: Texture profile analysis (TPA) test method of the gel 
Test Type TPA (Texture Profile Analysis) 
Pre-Test Speed 2.0 mm/s 
Test Speed 0.5 mm/s 
Post-Test Speed 0.5 mm/s 
Target Type Distance – Gel 
Target Value 4 mm 
Trigger Force 7 g 
Peak load  32 g 
Deformation at peak load 1.49 mm  
Parameters Work cycle performed  Test results 
Hardness  Deformation 3.97 mm 
Recoverable deformation  1.06 mm 
Adhesion  Adhesiveness  0.4 mJ 
Resilience  0.22 
Stringiness Length 1.97 mm 
Stringiness 0.1 mJ  
Fracturability  Peak load  7 g 
Fracture deformation  0.03 mm  
Cohesion Cohesiveness 0.98  
Recoverable deformation  1.19 mm  
Recoverable work  0. 1 mJ  
Springiness Springiness  3.08 mm  
Springiness index  0.77 
 
 
Measurement of Spreadability: Spreadability characterizes 
the scope of the gel to spread easily during application. 
Mucoadhesive polymers, by viscosity, demonstrate such 
properties. Gel spreadability is inversely proportional to its 
viscosity. Such properties are always desirable for an in-situ 
gel formulation to deliver active drugs for an ailment.24  
In vitro mucoadhesive strength: Table 5 shows the 
mucoadhesion values of the experimental gel. The present 
gel demonstrated mucoadhesive strength to pick the goat 
cheek mucosa up to 3.61 mm. This mucoadhesive property is 
required for retention of the drug-containing gel in situ for 
better drug release with minimal wastage of the drugs. For 
the present formulation, mucoadhesion was seen up to 3.61 
mm. 
 
Table 5: Mucoadhesion, spreadability, tensile strength of the gel 
 
 
 
 
 
 
 
 
 
 
Test Type Spreadability  Mucoadhesion  Tensile strength  
Pre-Test Speed 2.0 mm/s 2.0 mm/s 2.0 mm/s 
Test Speed 0.5 mm/s 0.01 mm/s 0.5 mm/s 
Post-Test Speed 0.5 mm/s 4.5 mm/s 0.5 mm/s 
Target Type Distance – Gel Distance – Gel Distance – Gel 
Target Value 1.5 mm 4 mm 1.5 mm 
Trigger Force 13 g 7 g 7 g 
Peak load  19 g 19 g 25 g 
Deformation at peak load 1.49 mm  3.61 mm  3.92 mm  
Dahake et al                                                                                                                         Journal of Drug Delivery & Therapeutics. 2020; 10(4):59-66 
ISSN: 2250-1177                                                                                        [65]                                                                                    CODEN (USA): JDDTAO 
Measurement of tensile strength: Table 5 reveals the 
tensile strength of the gel formulation. When a peak load of 
25 g was applied to the gel at a speed of 0.5 mm/s, the gel 
could bear a tensile strength deformation of up to 3.92 mm. 
The internal factors modulating the tensile strength of a gel 
are the percentage distribution of individual composition, 
adhesion of unlike molecules, and cohesion of like molecules 
from the ingredients. However, some extrinsic inducements 
can alter the tensile strength as, the variabilities in force, 
temperature, and environment.22  
Syringability study: Table 6 reveals the syringeability of the 
present gel formulation in detail. When present chitosan-
poloxamer gel formulation was refrigerated, it maintained 
its sol form, while at room temperature of 25-270C, it lost 
syringeability within 2-3 mins. At 250C, the gel could be 
easily withdrawn through a 25G and 22G needle. Between 
25-270C, gel exhibited some resistance to the 25G needle but 
extruded easily from the 22G needle. Hence, the formulation 
can be considered as “easily injectable suspensions” in 
refrigerated conditions as a sol, suitable for parenteral 
application. After 270C, the particles started coagulating, 
requiring the application of little force to inject the solution 
through the 25G needle and can be termed as injectable gels. 
Between 27-300C, it was difficult to extrude the gel from the 
25G needle but could be expressed easily through a 22G 
needle. Beyond 300C, it was difficult to extrude the gel 
through a 25G needle, but from a 22G needle requiring extra 
pressure and emerged as droplets. Beyond 330C gel did not 
extrude from the 22G needle also. 
     
Table 6: Syringeability of the gel formulation at various temperatures 
Temperature Extrusion from 25 G needle Extrusion from 22 G needle  
< 250C Easily - as sol Easily - as sol 
25 – 27 Some resistance - as gel  Easily - as sol  
27 – 30  More resistance - as coagulated drop  Some resistance - as gel  
30 – 33  Extreme resistance – no extrusion  More resistance as - coagulated drop  
> 33  Extreme resistance – no extrusion   Extreme resistance – no extrusion  
 
 
Biodegradability test: Graph 2 demonstrates the 
biodegradation profile of the gel formulation, due to the loss 
of poloxamer, chitosan, and other crosslinking agents due to 
high water solubility respectively, in the presence of 
lysozyme. The results revealed that the developed gel was 
biodegraded due to the liberation of reduced sugar from it.26 
The degradation rate for the experimental gel gradually 
increased from 1st to 10th day, ranging from 7% to more than 
60% of the total volume. However, this property is favorable 
for the intended use of the gel in situ. The present 
observation can be justified by the presence of all the 
hydrophilic water-soluble ingredients, and their high 
biodegradability. The lysosomal adsorption by this gel is 
attributed to the presence of several functional hydrophilic 
NH2, OH-, and COOH groups in these agents.25,31  
SEM Analysis of the gel: Figure 2 represents the SEM 
analysis of the gel formulation. It represents a three-
dimensional interconnected meshwork of all the ingredients 
used, without phase separation. The structural 
arrangements of the polymeric contents look like a blend of 
polymeric molecules; their orientation is unidirectional, 
suggesting good adhesion and cohesion of the polymers at 
1000X magnification. The average particle diameter was 
found to be between 300 and 554 nm.  
 
Graph 2 – Biodegradation of the gel formulation in 
lysosome solution
 
 
Figure 2: SEM analysis of the gel formulation 
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CONCLUSIONS 
After the evaluation of the formulation, it can be concluded 
that all the ingredients in the gel showed good compatibility 
with each other, which could form a stable and homogeneous 
gel with favorable mechanical and physical properties. This 
biodegradable gel base can be used as a carrier for various 
drug moieties with prolonged residence time. However, 
further in vitro and in vivo studies are recommended in the 
future for bringing this formulation in practical use.    
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